Back in 1989, scientists have found a kind of heat shock proteins (HSP), named Hsp90α, which existed in human bodies and can be used as a cancer biomarker detection kit.
早在1989年,科学家们就已经发现了热休克蛋白90α。这种热休克蛋白存在于人体内,可用作肿瘤生物标志物检测试剂盒。
Scientists around the globe have been working on it since then, and more than 10,000 journals have been published on accredited magazines, yet no one has actually turned their research results into medical products.
此后,世界各国的研究团队已经围绕这种蛋白,在权威杂志上发表了1万多篇论文,然而还没有人把研究成果转化为医疗产品。
However, Luo and his team seemed to have cracked the code, after working on the problem since 2009. The team has produced an artificial Hsp90α protein that gains structural stability by regrouping proteins. This means they are able to "create" the protein, in any quantity, and at any time they wish to.
罗永章及其团队自2009年开始研究这一问题,而他们似乎已经攻克难题。研究小组通过重组蛋白质制备出结构稳定的人工热休克蛋白90α。这意味着他们可以随时随意“生产”任意数量的热休克蛋白90α。
The kit has since been used in clinical trials involving 2,347 patients at eight hospitals in China. It was the first clinical trial in the world to test if the protein could be a useful tumor biomarker for lung cancer, and it succeeded.
【一滴血可“监测肿瘤”,已被批准临床使用】相关文章:
最新
2019-01-07
2019-01-07
2019-01-07
2019-01-07
2019-01-07
2019-01-05